跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 佩靖
教授
腫瘤惡化卓越研究中心
微生物及免疫學研究所
https://orcid.org/0000-0001-8665-5494
電話
02-282667111
電子郵件
pcchang
nycu.edu
tw
h-index
h10-index
h5-index
1364
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
769
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
365
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2000
2023
每年研究成果
概覽
指紋
網路
研究成果
(34)
類似的個人檔案
(6)
指紋
查看啟用 Pei-Ching Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Apoptosis
11%
Autophagy
26%
Autophagy Pathway
18%
Castration-resistant Prostate Cancer
17%
Chromatin
12%
Chromatin Immunoprecipitation (ChIP)
12%
COVID-19
10%
Epigenetic Regulation
11%
Herpesvirus
13%
Herpesvirus Reactivation
21%
Heterochromatin
11%
Histone Demethylase
25%
Hormone Refractory
13%
Hormone-sensitive Prostate Cancer
10%
IFN Signature
17%
Innate Immune Checkpoint
17%
JMJD2A
17%
K-bZIP
24%
Kaposi's Sarcoma-associated Herpesvirus
92%
KDM4A
17%
Knockdown
18%
Latency
13%
Latency-associated nuclear Antigen
17%
LNCaP Cells
11%
Long Non-coding RNA (LncRNA)
34%
Lupus Nephritis
17%
Neuroendocrine Differentiation
29%
Neuroendocrine Prostate Cancer
11%
NLRP12
17%
Non-coding RNA (ncRNA)
10%
Overexpression
13%
Phosphorylation
20%
Post-translational Modification
15%
Prostate Cancer
26%
Prostate Cancer Cells
42%
RE1-silencing Transcription Factor
19%
Small Ubiquitin-like Modifier
25%
SUMO Modification
10%
SUMO1
13%
SUMO2
25%
SUMOylation
36%
Transcription Factor
20%
Ubiquitin-like
17%
Viral
35%
Viral Gene
12%
Viral Genome
11%
Viral Reactivation
20%
Viral Replication
11%
Virus
20%
Virus Latency
17%
Biochemistry, Genetics and Molecular Biology
2,5-Dimethoxy-4-iodoamphetamine
8%
Autophagy
25%
Cancer Cell
32%
CD44
8%
Cell Migration
12%
Chromatin Immunoprecipitation
13%
Colony Forming Cell
8%
Demethylase
29%
Downregulation
12%
Drug Resistance
8%
Epigenetics
29%
Episome
11%
Gene Expression
14%
Herpesviridae
9%
Heterochromatin
13%
Histone
31%
HOTAIR
8%
Human Cytomegalovirus
8%
Human Herpesvirus 8
100%
Human Immunodeficiency Virus
8%
Infrared Radiation
8%
Interleukin 10
10%
Interleukin 6
9%
JMJD2A
17%
Krüppel Associated Box
8%
LNCaP
11%
Long Non-Coding RNA
18%
Long Noncoding RNA
17%
Mesenchymal-Epithelial Transition
8%
Metabolite
8%
Methyltransferase
17%
P53
14%
Programmed Cell Death
9%
Promoter Region
10%
Proteasome
8%
Protein Kinases
9%
Repressor
19%
RNA
10%
RNA Sequencing
8%
Sumoylation
39%
Transactivation
18%
Transcription
11%
Transcription Factors
28%
Tumor Suppressor Protein
9%
Ubiquitin
25%
Ubiquitin Ligase
28%
Viral Protein
10%
Virus Gene
18%
Virus Genome
10%
Virus Replication
12%
Immunology and Microbiology
2,5-Dimethoxy-4-iodoamphetamine
8%
Antiviral Activity
8%
Arginine
8%
Cell Migration
7%
Colony Forming Cell
8%
Coronary Artery
8%
Cycline
8%
Downregulation
13%
Enterovirus A71
8%
Episome
9%
Exosome
5%
Gene Expression
15%
Herpesviridae
13%
Heterochromatin
14%
Histone
30%
Human Cytomegalovirus
8%
Human Herpesvirus 8
91%
Human Immunodeficiency Virus
8%
Human Immunodeficiency Virus 1
8%
Immunity
27%
Infrared Radiation
8%
Interleukin 10
10%
Krüppel
8%
LANA
17%
Life Cycle
6%
Lupus Erythematosus
17%
Lysine
7%
Metabolite
8%
Methylation
8%
Middle East Respiratory Syndrome Coronavirus
8%
Muscle
8%
Myotube
8%
Nephritis
17%
NLRP12
17%
P53
13%
Post-Translational Modification
13%
Promoter Region
15%
Proteasome
8%
RNA Sequencing
6%
SARS Coronavirus
8%
Severe Acute Respiratory Syndrome
8%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Sumoylation
27%
Transactivation
17%
Ubiquitins
17%
Viral Protein
10%
Viral Replication
13%
Virus
33%
Virus Gene
19%
Virus Genome
11%
